The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Patient, Investigator Reflect on Advancements in Lupus, Rheumatoid Arthritis Treatments

Rheumatology Patient, Investigator Reflect on Advancements in Lupus, Rheumatoid Arthritis Treatments

November 16, 2016 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Foundation-supported investigator Amit Golding, MD, PhD, is working to better understand why the immune system turns against itself in such diseases as lupus and rheumatoid arthritis.

Foundation-supported investigator Amit Golding, MD, PhD, is working to better understand why the immune system turns against itself in such diseases as lupus and rheumatoid arthritis.

In 1969, Martha Lovato passed away from renal failure due to complications of lupus. Martha was 18 years old and survived only two years following her diagnosis. At the time, Martha’s disease was still a mystery to many physicians and researchers. Her treatment options were limited.

You Might Also Like
  • Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments
  • Rheumatology Research Foundation Funding Enables Potential Treatment Advancements
  • Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
Explore This Issue
November 2016
Also By This Author
  • Fighting Lupus Among Latinas

In fall 2004, after an unprecedented battle with shingles and stubborn joint pain, Martha’s sister, Yolanda Grundhoffer, received an unexpected diagnosis of lupus and rheumatoid arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“I had been tested when I was younger. It never crossed my mind that the doctor would tell me I had lupus. Just the word was taboo in my family.”

Although her life has changed dramatically since her initial diagnosis, the treatment she receives from her rheumatologist has given her the ability to live a nearly normal life. The memory of her sister is among her biggest motivators to stay strong in the face of disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Even though I was young [when Martha became ill], I remember brushing her hair, putting hot towels on her aching joints and telling her stories while she cried from the pain. There are mornings I wake up still exhausted from the day before, and I don’t want to get out of bed. But I think of Martha and how the disease affected her, and I keep going. I know she would be upset if I gave up.”

Advancements in treatment options gave Yolanda the chance to live the life her sister was unable to. Yolanda is still hopeful for more research breakthroughs, but she is grateful for the increased longevity and quality of life for patients with rheumatic diseases. “If my sister had the medicine of today, she would be alive. I’m sure of it. So as we progress, and we study the genetics of people with certain diseases, I am sure we will get to the point of early detection. Even, one day, a cure.”

With the help of her rheumatologist, Yolanda Grundhoffer lives a nearly normal life with lupus and rheumatoid arthritis. Yolanda’s sister passed away from lupus complications in 1969.

With the help of her rheumatologist, Yolanda Grundhoffer lives a nearly normal life with lupus and rheumatoid arthritis. Yolanda’s sister passed away from lupus complications in 1969.

Amit Golding, MD, PhD, physician scientist and assistant professor at the University of Maryland, also sees the importance of continuing progress in treatment advancements. “We have so many tools right now to treat patients, and at the same time, we have so many questions about what is causing the underlying conditions.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College, Rheumatoid Arthritis, SLE (Lupus) Tagged With: advances, Dr. Amit Golding, Lupus, Medication, patient care, Rheumatoid arthritis, Rheumatology Research Foundation, SLE, Treatment, Yolanda GrundhofferIssue: November 2016

You Might Also Like:
  • Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments
  • Rheumatology Research Foundation Funding Enables Potential Treatment Advancements
  • Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
  • ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.